Costs awarded against Society in FTP case
Costs, estimated at £20,000, have been awarded against the Royal Pharmaceutical Society following unsuccessful disciplinary proceedings against two pharmacists. This is the first time the Disciplinary Committee has used new powers to award costs in fitness-to-practise proceedings.
The Society alleged that two brothers who jointly owned a community pharmacy
with their third brother were guilty of misconduct because the third
brother incorrectly endorsed a number of NHS prescriptions. The two brothers
were not involved with the running of the pharmacy.
The Society was ordered to pay legal costs incurred by the brothers following
a case management hearing in August 2007 at which the Society was asked
what they were alleged to have done wrong. The Society said that it did
not have to answer and referred to a passage in the code of ethics which
says that pharmacists have a personal and professional responsibility
for anything that goes wrong at a pharmacy they own.
At a hearing in January 2008, the Disciplinary Committee dismissed the
case against the two brothers, accepting legal arguments that there was
nothing they could be said to have done wrong. In reaching its decision,
the committee referred to a previous case in which an allegation of misconduct
against a partner had been rejected, and to Article 7 of the European
Convention on Human Rights and to the Common Law.
David Reissner, a partner in Charles Russell LLP and head of its healthcare
team, said: “This decision is significant for two reasons: it shows
yet again that mere ownership of a pharmacy is not enough to justify
disciplinary proceedings if something goes wrong; and regulators like
the Royal Pharmaceutical Society are accountable if they take the very
serious step of instituting disciplinary proceedings which can have devastating
consequences for individuals who may have allegations hanging over their
heads for years.”
Rosalyn Hayles, head of investigations and hearings at the Society, said: “The
Society will now take some time to consider the implications of this
decision but it is too early to comment further at this stage.”
|